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Objective.This study investigates the safety and efficacy of a multimodality approach combining staged endovascular embolizations
with subsequent SRS for themanagement of larger AVMs.Methods.Ninety-five patients with larger AVMs were treated with staged
endovascular embolization followed by SRS between 1996 and 2011. Results.Themedian volume of AVM in this series was 28 cm3
and 47 patients (48%) were Spetzler-Martin grade IV or V. Twenty-seven patients initially presented with hemorrhage. Sixty-one
patients underwent multiple embolizations while a single SRS session was performed in 64 patients. The median follow-up after
SRS session was 32 months (range 9–136 months). Overall procedural complications occurred in 14 patients. There were 13 minor
neurologic complications and 1 major complication (due to embolization) while four patients had posttreatment hemorrhage.
Thirty-eight patients (40%) were cured radiographically. The postradiosurgery actuarial rate of obliteration was 45% at 5 years,
56% at 7 years, and 63% at 10 years. In multivariate analysis, larger AVM size, deep venous drainage, and the increasing number
of embolization/SRS sessions were negative predictors of obliteration. The number of embolizations correlated positively with the
number of stereotactic radiosurgeries (𝑃 < 0.005). Conclusions. Multimodality endovascular and radiosurgical approach is an
efficacious treatment strategy for large AVM.
1. Introduction
Cerebral arteriovenous malformations (AVM) are rare but
potentially devastating vascular lesions that often affect
young adults. Intracranial hemorrhage occurs at an average
annual rate of 2 to 4% [1]. Surgical excision is the main-
stay of treatment for Spetzler-Martin (SM) grade I and II
AVM. Because of high procedural morbidity rates, surgery
is avoided in larger and higher grade AVM, and alternative
therapies are often considered for these lesions.
Radiosurgery, initially conceived by Leksell [2] in 1968, is
a well-established treatment alternative to surgical resection
for intracranial AVM. However, stand-alone stereotactic
radiosurgery (SRS) may have limited utility for larger AVM
[3]. For these larger lesions, we have explored amultimodality
therapy of initial endovascular embolization forAVMvolume
reduction followed by SRS to treat the remaining nidus. By
reducing the size of the nidus targeted by SRS, endovascular
embolization is thought to improve AVM obliteration rates
while also minimizing SRS-related complications. Previous
series have reported conflicting results regarding the efficacy
of preradiosurgical AVM embolization [4]. We report our 15-
year experience in managing these challenging lesions with a
combined embolization and SRS approach.
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Figure 1: 57 yo M presenting with incapacitating migraines found in frontal and lateral views of digital subtraction angiogram, left carotid
injection, to have Spetzler-Martin grade III left parietal AVM (a-b). Frontal and lateral views of digital subtraction angiogram showing
reduction of AVM nidus after 1st endovascular embolization with NBCA (c-d). Frontal and lateral views of digital subtraction angiogram
following third NBCA embolization session with remaining small nidus and fistula (e-f). Frontal and lateral views of digital subtraction
angiogram showing small remaining nidus and fistula prior to Gamma Knife SRS planning (g-h). Frontal and lateral views of digital
subtraction angiogram showing complete obliteration of AVM 2 years after SRS session (i-j).
2. Methods
2.1. Patient Selection. An Institutional Review Board approv-
al was obtained prior to data collection. From 1996 to 2011,
a total of 775 patients were treated for cerebral AVM in
our institution. Of these, 95 patients were selected based on
their clinical presentation, SM grade, and angioarchitecture
to undergo staged embolization and SRS as seen in Figure 1.
We were more likely to aggressively utilize radiosurgery with
adjuvant embolization than any treatment at all in those
patients with hemorrhagic presentation, SM grade II–IV, and
those with arterial pedicles amenable to embolization. All
patients had larger AVMs with a maximal diameter greater
than 3 cm.
Medical charts, operative reports, SRS records, and
pre- and posttreatment imaging results including MR
and digital subtraction angiography (DSA) were carefully
reviewed to determine patient demographics, AVM char-
acteristics, procedural complications, posttreatment cerebral
hemorrhage, radiological AVM obliteration, and neurologi-
cal outcome.
2.2. Embolization Protocol. Embolization was performed
with liquid embolic agents NBCA (Codman & Shurtleff, Inc.,
Raynham, Massachusetts, USA) and, later, Onyx 18 or 34
(eV3, Irvine, CA). Embolization sessions were performed
at 6-week intervals, as necessary, until the AVM nidus had
been reduced by a goal of 33% (usually to a volume of less
than 10 cc). Target selection for AVMs was dependent on two
issues, the size of feeding arterial pedicles and the location of
arterial feeders on theAVMnidus. Targets were often selected
that would treat and obliterate deeper portions of the nidus
and those with large volume. Our strategy with embolization
was to achieve volume reduction and not flow reduction and
ideally to target fixed portions of a nidus that would allow for
a discrete nidus when targeting with SRS. Postembolization
AVM size was calculated during SRS planning.
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2.3. Stereotactic Radiosurgery Protocol. A stereotactic head
frame was placed for all patients using local anesthesia
supplemented by intravenous sedation. Next, biplane digital
subtraction stereotactic angiographywas performed followed
by MR imaging (Figures 1(g) and 1(h)). Volumetric 3D dose
planning was performed using Leksell GammaPlan software.
For patients with larger lesions and prospectively volume-
staged SRS plans, the lesion was divided into approximately
equal volumes using anatomic landmarks. SRS treatment
plans consisted of the margin SRS dose including the entire
AVMnidus volume. SRSwas performedwith Leksell Gamma
Knife units (Elekta AB).
The median initial AVM volume was 28 cm3 (largest
being 112 cm3). The mean Flickinger Pollock grade was 3.65
(range 1.1 to 11.8).
The postembolization mean maximal diameter was
2.2 cm (range 0.3–6 cm). The median total target volume was
4.24 cm3 (range 0.26–9.1 cc3) on the first SRS treatment and
5.09 cm3 on successive SRS treatments. The median margin
dose was 21 Gy.
2.4. Follow-Up Evaluation. Radiological success was defined
as complete AVM obliteration on DSA (total disappearance
of the nidus and early draining veins) or, alternatively, on
MR angiography (total disappearance of the nidus and flow-
voids) for patients with poor overall medical condition or for
those refusing follow-up DSA. The median follow-up after
SRS session was 32 months (range 9–136 months).
2.5. Statistical Analysis. Data are presented as median and
range for continuous variables and as frequency for categor-
ical variables. The Flickinger Pollock scale was tested as a
continuous variable and as an ordinal variable by quartile.The
Radiosurgery AVM Score was tested as previously described
[5]. Kaplan Meier analysis was carried out to determine
actuarial rate of obliteration. Univariate survival analysis was
carried out using the logrank test to test covariates predictive
of treatment obliteration. Factors predictive in univariate
analysis (𝑃 < 0.20) were entered into a multivariate Cox
proportional hazards model. Interaction and confounding
was assessed through stratification and relevant expansion
covariates. 𝑃 values of ≤0.05 were considered statistically
significant. Statistical analysis was carried out with Stata 10.0
(College Station, TX).
3. Results
Ninety-five patients with large and complex AVMunderwent
preoperative embolization followed by SRS. Patient charac-
teristics are summarized in Table 1. Of the 95 patients, 41
(43%) were women and 54 (57%) were men. The median age
was 39 years (range 9–73 years).Thirty-six percent of patients
were active smokers and 23% were on oral antihypertensive
medication at the time of diagnosis.
AVMs were predominantly located in the left hemisphere
(57%). The parietal lobe was the most common location
of AVM (27%). The median maximum diameter of AVMs
was 4.3 cm. Sixteen (17%) AVM had a maximum diameter
Table 1
𝑁 %
Gender
M 41 42%
F 54 58%
Age
Median in yrs 38.54
0–21 18 18.90%
22–40 yrs 32 33.70%
40–50 yrs 22 23.20%
50+ 23 24.20%
AVM side
L 54 57%
R 41 43%
Initial hemorrhage
N 68 71%
Y 27 29%
Initial seizure
N 58 61.10%
Y 37 38.90%
Initial neurological exam
Intact 74 78.00%
Mild/moderate deficit 18 18.90%
Severe deficit (i.e., unresponsive) 3 3.10%
Location 𝑁 %
Frontal 19 20.00%
Temporal 24 25.30%
Parietal 26 27.40%
Occipital 9 9.40%
Cerebellum 8 8.40%
Thalamus, brainstem 9 9.40%
Size
Medium (3–6 cm) 80 84.20%
Large (>6 cm) 15 15.80%
Eloquence
Noneloquent tissue 24 25.20%
Eloquent tissue 71 74.80%
Venous drainage
Superficial 44 46.30%
Deep 51 53.70%
SM grade
3 48 50.50%
4 38 40.00%
5 9 9.50%
Pollock-Flickinger score
0–2.25 23 24.2%
2.25–3.5 24 25.3%
3.5–4.75 24 25.3%
>4.75 24 25.3%
Radiosurgery AVM scale
1 12 12.6%
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Table 1: Continued.
𝑁 %
2 46 46.3%
3 28 29.4%
4 11 11.6%
greater than 6 cm. The median pretreatment volume was
28 cm3. Mean SM grade was 3.6 and almost 50% (47/95)
of all lesions were SM grade IV or V. Seventy-one (75%)
AVMs were located in eloquent areas and 51 had deep venous
drainage (54%). Twenty (29%) patients initially presented
with cerebral hemorrhage, and 37 (39%) presented with
seizures. The remaining patients were initially diagnosed
incidentally or as part of the imaging workup for headaches.
In our patient population therewere 5 patientswith intranidal
aneurysms (5%), 1 patient with a high flow fistula (1%),
and 9 patients with proximal flow-related aneurysms treated
(10%). The mean Flickinger Pollock scale was 3.65 (standard
deviation 1.95). The mean Radiosurgery AVM Score was 2.4.
Thirty-four (36%) patients underwent a single emboliza-
tion, 25 (26%) patients underwent 2 embolizations, 15
patients (16%) underwent 3 embolizations, and 21 patients
(22%) underwent ≥4 embolizations (Tables 2 and 3). A single
SRS session was performed in 64 (67%) patients, two SRS
sessions in 17 patients (18%), and three to five SRS sessions in
14 (15%) patients. The median duration from last SRS session
to follow-up was 32 months.
Overall procedural complications occurred in 14 (14.7%)
patients. Thirteen (14%) patients experienced only minor or
transient neurological complications that left no permanent
morbidity. The remaining patient suffered a major neuro-
logical complication following embolization that left him
severely disabled. Four (4%) patients suffered a hemorrhage
during the follow-up period. One expired shortly thereafter.
Thirty-eight (40%) patients had a radiographically confirmed
obliteration. AVM obliteration was confirmed on DSA in 31
patients (32%) and MRA in 7 patients (8%).
Statistical analysis is detailed in Tables 4 and 5. In mul-
tivariate logistic regression analysis, larger AVM size, deep
venous drainage, and increasing number of embolization or
SRS sessions were negative predictors of complete oblitera-
tion. The number of embolizations correlated positively with
the number of stereotactic radiosurgeries (𝑃 < 0.005). We
analyzed patients who had a favorable outcome (complete
obliteration and no neurologic deficits). Those with less than
4 embolization treatments (OR = 0.26, 𝑃 = 0.036) and
without deep venous drainage (OR = 0.22, 𝑃 = 0.001)
were significantly more likely to have favorable outcome.The
postradiosurgery actuarial rate of obliteration was 36% at 3
years, 45% at 5 years, 56% at 7 years, and 63% at 10 years
(Figure 2).
4. Discussion
In AVMs deemed inappropriate for surgical resection, SRS
is a well-established treatment alternative. Large series have
reported excellent results with occlusion rates as high as
0.00
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Figure 2: Plot showing AVM obliteration rate versus time after
treatment.
Table 2
Total number of
embolizations 𝑁 (mean 2.44) %
1 34 35.80%
2 25 26.30%
3 15 15.80%
4+ 21 22.10%
Time to complete multiple
embolizations Avg months (mean 7.7) 𝑁
2 embolizations 1.9 28
3 embolizations 7.8 17
4 embolizations 11.3 15
5+ embolizations 30.8 11
Type of embolization 𝑁 %
NBCA 230 83%
Onyx 46 17%
Total number of radiation
treatments 𝑁 %
1 64 67.30%
2 17 17.90%
3+ 14 14.70%
Table 3
SRS Tx Total embo Tx
1 2 3 4 5 6 7
1 28 17 10 7 1 1 0
2 5 4 2 5 1 0 0
3 1 3 2 0 2 0 1
4 0 1 0 1 0 1 1
5 0 0 1 0 0 0 0
Spearman’s rho 0.403, 𝑃 < 5.982𝑒 − 6.
84% at 2-year angiographic follow-up [6]. Pollock et al.
[7] reported a 73% rate of complete obliteration and a
14% rate of major complications. In their study, the rate
of hemorrhage after treatment was 8% over a 2–5 year
BioMed Research International 5
Table 4
Total (%) No. w/residual AVM (%) No. w/100% obliteration (%) 𝑃 value
Sex, 𝑛 (%) 0.396
M 41 21 51.20% 20 48.80%
F 54 36 66.70% 18 33.30%
Age, 𝑛 (%) 0.795
0–21 18 10 55.60% 8 44.40%
22–40 yrs 32 21 65.60% 11 34.40%
40–50 yrs 22 14 63.60% 8 36.40%
50+ 23 12 52.20% 11 47.80%
Location 0.252
Frontal 19 14 73.70% 5 26.30%
Temporal 24 13 54.20% 11 45.80%
Parietal 26 12 46.20% 14 53.80%
Occipital 9 7 87.80% 2 22.20%
Cerebellum 8 4 50% 4 50%
Thalamus, brainstem 9 7 87.80% 2 22.20%
Size, 𝑛 (%) 0.022
Medium (3–6 cm) 80 44 55% 36 45%
Large (>6 cm) 15 13 86.70% 2 13.30%
Venous drainage, 𝑛 (%) <0.001
Superficial 44 18 40.90% 26 59.10%
Deep 51 39 76.50% 12 23.50%
Smoker? 𝑛 (%) 0.664
Y 35 20 57.10% 15 42.90%
N 60 37 61.70% 23 38.30%
Hypertension? 𝑛 (%) 0.669
Y 18 11 61.10% 7 38.90%
N 77 46 59.70% 31 40.30%
Table 5
Total (𝑛) No w/residual AVM No. w/100% obliteration 𝑃 value
% %
Initial hemorrhage 0.926
Y 27 16 59% 11 41%
N 68 40 59% 28 41%
Initial seizure 0.731
Y 37 25 68% 12 32%
N 58 31 53% 27 47%
Initial neurological exam 0.25
Intact 74 45 61% 29 39%
Mild/moderate deficit 18 8 44% 10 56%
Severe deficit 3 3 100% 0 0%
Total number of embolizations 0.017
1 34 18 53% 16 47%
2 25 13 52% 12 48%
3 15 8 53% 7 47%
4+ 21 17 81% 4 19%
Total number of radiation treatments 0.025
1 64 33 52% 31 48%
2 17 12 72% 5 29%
3+ 14 12 79% 2 14%
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follow-up period. Along similar lines, Yashar et al. [8]
reported a 4-year radiographic obliteration rate of 67% with
a hemorrhage rate of approximately 8%. With increasing
clinical experience, several predictors of outcome after SRS
were identified including AVM nidus volume, geometry of
nidus distribution, eloquence of surrounding brain, and the
presenting symptom of hemorrhage [5].
Despite overall high obliteration rates and low compli-
cation rates, SRS efficacy remains severely limited in large
and complex AVM. In fact, SRS treatment efficacy and safety
profile diminish sharply with increasing AVM size [4]. In
a series of 30 large AVMs, Miyawaki et al. [9] noted only
a 23% obliteration rate when utilizing a LINAC dose of
16Gy with 22% of these cases requiring surgical intervention
due to symptomatic radiation necrosis. Using LINAC with a
mean dose >10Gy, Ellis et al. [10] reported an obliteration
rate of 44% in AVMs larger than 10 cm3. Results from
single-session Gamma Knife Radiosurgery (GKR) have been
similarly discouraging for large AVM. Pan et al. [11] reported
only a 50% obliteration rate in 76 AVMs larger than 10 cm3
(mean dose 17Gy). Furthermore, the authors reported that
49% of their patients had developed moderate to severe
radiation-related edema with 6.3% having treatment related
symptomatic complications.
Given the poor efficacy of SRS in large and complex
AVM, neurosurgeons have attempted to develop alternative
treatment strategies. Our center and others have utilized
endovascular embolization to reduce the volume of large
AVM in an attempt to improve SRS efficacy.With a reduction
in the size of these lesions by embolization, SRS may poten-
tially prove as effective as in initially small AVM treated with
appropriate SRS margin dosages. Mathis et al. [12] embolized
24 AVMs with a mean initial volume of 37 cm3 prior to GKR
and noted a 50% obliteration rate with only 4% morbidity.
In their series, procedural morbidity was exclusively related
to radiosurgery. In another series, Mizoi et al. [13] treated 14
patients with AVMs >3 cm (mean volume 17.9 cm3) with par-
ticle embolization followed by GKR (19.2Gy) and reported
a 38% obliteration rate with an 11% permanent morbidity
rate (related exclusively to the endovascular embolization).
In these initial reports, particulate agents such as PVA
were utilized. These agents have several drawbacks mainly
related to treatment durability and technical complications.
Since then, newer embolic agents with improved penetrance,
selectivity, and safety profile have been developed. Gobin et
al. [14] reported their experience with NBCA embolization
followed by LINAC (25Gy) in large AVM (mean initial
volume 22 cm3). The authors were able to achieve a cure in
60% of patients with a 12.6% morbidity rate due primarily
to the endovascular procedure. More recently, Blackburn et
al. [15] reported an impressive 84% obliteration rate in 19
patients with AVM (average size of 20.1 cm3) treated with
NBCA embolization (average of 2.1 sessions) followed by
SRS (mean dose of 17.9 Gy at the 50% isodense line). The
procedural morbidity rate was 19% in their series. Blackburn
reported a 7% permanent morbidity rate per endovascular
embolization and 5% permanent morbidity rate per SRS
session.
Our experience with embolization prior to SRS has been
positive, albeit with amoremodest 40%obliteration rate. Our
criteria for radiographic AVM cure included only patients
in whom a frank obliteration was documented on DSA
or, alternatively, on MRA in those unable or unwilling to
undergo catheter angiography. We also attribute this lower
angiographic cure rate to the higher proportion of patients
with SM grade IV/V lesions and the larger median AVM size
in our study. Median AVM volume was as high as 28 cm3 and
nearly 50% of all lesions were SM grade IV and V.
Our protocol had a safety profile with a rate of morbidity
of 14%.Most importantly, although 29% of patients presented
with a ruptured AVM, only 4 (4%) patients experienced
a posttreatment hemorrhage. This low rate of hemorrhage
should be interpreted in light of the poor natural history of
the AVMs included in our study. As such, young patients,
known to have a particularly high rupture risk as demon-
strated by Laakso et al. [16], accounted for up to 50% of the
study population.Many patients also had larger symptomatic
lesions in or abutting eloquent locations with medically
intractable epilepsy or continued neurologic decline.The risk
of open surgery is prohibitively high in these patients, and
without preradiosurgical embolization many would not have
been treatable with SRS alone due to the risks of high dose
SRS radiation necrosis.
Despite the positive results previously reported by centers
undertaking embolization, the use of embolization as an
adjunctive tool in the treatment of large AVMs remains con-
troversial. Some investigators reported that embolizationmay
decrease obliteration rates and increase treatment morbidity
[17]. Andrade-Souza et al. [17] retrospectively matched 47
patients who underwent Embo/SRS with 47 patients treated
with SRS alone. They found an obliteration rate of 47%
with Embo/SRS compared to 70% with SRS alone. However,
this study is severely limited by the difficulty in matching a
complex group of patients retrospectively, which may have
introduced significant bias into the analysis. The authors
also theorized that the lower obliteration rate observed
with preradiosurgical embolization was attributable to the
recanalization of the embolized portion of the nidus as well as
the difficulty with radiosurgical planning since embolization
may convert a fairly uniform geometric target into a poorly
defined target with multiple irregular components. However,
newer liquid embolic agents, such as Onyx, offer significant
improvements in these areaswhichmay theoretically increase
treatment success.
Other groups have utilized different radiosurgical strate-
gies to manage large unresectable AVM. Karlsson et al. [18]
presented their data with planned staged SRS beginning with
a low initial dose for volume reduction followed several
years later by a follow-up SRS treatment. They treated 19
AVMs with an average volume of 16 cm3 and achieved an
obliteration rate of 68%, with a 7% risk of morbidity and a
7% annual risk of posttreatment hemorrhage. Using the same
strategy in a series of 41 patients with large AVM (average
volume of 13.8 cm3), Foote et al. [19] achieved an obliteration
rate of 59%, with a 2% permanent SRS-related morbidity
and a 1.5% annual risk of posttreatment hemorrhage. Purely
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volume-staged SRS is amore recently reported approachwith
prospectively planned follow-up SRS sessions on separate
portions of the AVM at six-month intervals. Richling et al.
[20] reported their initial results of volume-staged SRS with
28 large AVMs (average volume of 24.9 cm3) achieving a
33% obliteration rate with only a 4% complication rate.
A fairly similar obliteration rate (35%) was reported by
the same group in a follow-up report that included 48
patients with large AVM [21]. The authors cautioned against
the use of preoperative embolization, though nearly half
of their patients received some form of embolization. Of
their prospectively planned stereotactic staged radiosurgery,
the same authors reported a 36% actuarial obliteration rate
at 5 years and a 56% obliteration rate at 10 years when
including salvage treatments. Importantly, 10 hemorrhages
with 5 deaths occurred during follow-up, highlighting the
main limitation of this treatment strategy, namely, the slow
and delayed response of high risk AVMs to therapy.
We believe that the use of endovascular embolization
remains a valuable option as an adjunctive modality for
large AVM. We achieved a fairly reasonable obliteration rate,
which could potentially improve with further angiographic
followup. Furthermore, at the time of embolization, we
were able to treat high-risk fistulas and proximal flow-
related aneurysms as reflected in our low posttreatment
hemorrhage rate. Endovascular embolization may therefore
reduce the risk of hemorrhage during the treatment latency
period. Additionally, our treatment success came with a
low complication rate that compares favorably to previous
studies. The question of whether this complication rate is
better than the natural history of these lesions left untreated
cannot be definitively answered in the present study. For
some patients included in this study, SRS without prior
embolization or even surgical resection could have been
potential alternatives. Future advances in endovascular tech-
niques and liquid embolic agents will undoubtedly improve
the safety and efficacy of AVM embolization. Accordingly,
recent data may suggest that Onyx allows more permanent
lesion obliteration, with better visualization on SRS planning,
MR imaging, and less embolic complications; however, this
remains controversial [22].
5. Conclusions
SRS preceded by adjuvant embolization is a controversial
yet potentially efficacious treatment strategy in patients with
large AVMs that are not amenable to surgical excision.
We were able to achieve complete AVM obliteration in a
significant number of patients. Larger prospective studies are
needed to explore the long-term safety and efficacy of this
approach.
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